SLU-PP-332 5mg

SLU-PP-332 is a cutting-edge small molecule specifically designed as an agonist of the REV-ERB nuclear receptors (REV-ERBα and REV-ERBβ), key regulators of circadian rhythm, lipid metabolism, mitochondrial biogenesis, and inflammation. By binding to these transcriptional repressors, SLU-PP-332 enhances mitochondrial oxidative capacity, promotes efficient fatty acid utilization, and modulates inflammatory signaling pathways, resulting in improved metabolic flexibility and energy homeostasis.

Preclinical studies demonstrate that SLU-PP-332 can induce a shift toward a more oxidative metabolic state, reduce lipid accumulation, and enhance endurance without the need for external exercise stimuli — highlighting its therapeutic potential in managing obesity, metabolic syndrome, and age-related declines in mitochondrial function.

SLU-PP-332 exemplifies the next generation of metabolic therapeutics — where molecular precision meets biologic intelligence, offering a sophisticated, systems-based approach to optimizing human performance and longevity.

Inline with research best practices our solutions are sold in powdered form and require reconstitution prior to use. SLU-PP-332 is Hydrophobic and poorly soluble in water, we recommend you use an Acetic Acid solution.

For research purposes only.